Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of lacosamide, pregabalin, and tapentadol on pain-processing EEG biomarkers in healthy volunteers
2019-001204-37Phase 2Completed
- Sponsor
- Institute of Neuroscience
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lacosamide, pregabalin and tapentadol in pain, sponsored by Institute of Neuroscience. Primary endpoint: Change in LEP N2-P2 amplitude at 60 minutes. Started Jun 2019; status: completed.
02
Drugs
lacosamidepregabalintapentadol
03
Conditions
pain
Beyond the preview
Go deeper on 2019-001204-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001204-37.